The University of Kentucky Center for Clinical and Translational Science has been awarded a prestigious Clinical and Translational Science Award totaling $33.9 million for its work to innovate research methods, foster upcoming generations of researchers, and measurably improve health in the Commonwealth and beyond. CCTS has received four consecutive awards totaling $97.2 million from the National Center for Advancing Translational Sciences at the National Institutes of Health. UK President Eli Capilouto joined university research and CCTS leaders at a press conference today announcing the award.
First-year Ph.D. student Alexandra N. Johansen led a major systematic review published in Pharmacological Reviews, helping guide the search for effective treatments for methamphetamine use disorder and addressing a critical public health challenge.
https://t.co/raBHK2SvRK
👉Read this! Alex Johansen’s first paper out of the PAL in Pharmacological Reviews! Translational Medications Development for Methamphetamine Use Disorder: A Systematic Review of Preclinical, Human Laboratory, and Clinical Research - ScienceDirect https://t.co/ssODr6Lq36
CPDD is at @ASPET in Minneapolis this week! Stop by our booth to say hi to Heather and learn more about how we connect and support SUD and addition researchers.
We are looking forward to the 2026 #Alcohol GRC in Ventura, CA! The main meeting starts Feb 22, 2026 (GRS Feb 21-22). For both, we will be selecting additional invited talks from the submitted abstracts. For consideration, submit your abstract by Oct 10! #alcoholGRC2026
In this study where people with cocaine use disorder received money as a reward for negative cocaine tests (contingency management), reducing cocaine use helped improve cardiovascular health in individuals with cocaine use disorder.
@WilliamStoops
Link in bio
Offering hope beyond addiction.
Dr. Bill Stoops’ @NIH-funded research seeks to understand the development of substance use disorders and find new ways to help Kentuckians.
@UK_Supra_@UKYMedicine
Learn more: https://t.co/KXsIEUktgm
Research drives discovery at UK. Funding from the @NIH makes a difference. UK Acting Vice President for Research Ilhem Messaoudi explains how this funding impacts Kentuckians.
Learn more: https://t.co/BjWjQplhbT
Took a break from socials for Lent but this paper came out during that time, so I'm publicizing it now.
Very proud of our team's work to show benefits of non-abstinence cocaine treatment outcomes!
https://t.co/qxtVwEjoay
Last minute study section cancellation has been deeply disruptive and troubling to those submitting and those reviewing alike but it looks like those cancelled meetings can start being scheduled again.
https://t.co/eUbVWQu24a